This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eisai Co., Ltd.
Drug Names(s): E2212
Description: E2212 is a gamma secretase modulator. Gamma secretase is involved in the production of beta-amyloid, the major component of amyloid plaques seen in Alzheimer's disease. In preclinical studies, E2212 exhibited a more potent inhibition of the formation of amyloid beta (Aß42) by gamma secretase, apparently without impacting Notch-processing, a key process in normal cell differentiation that is also processed by gamma secretase.
Pink Sheet FDA Recalls For March 19, 2014
Additional information available to subscribers only: